You can buy Attruby at the lowest price at Nextgen.ooo online pharmacy. Acoramidis is a small molecule transthyretin stabilizer for use in patients with cardiomyopathy caused by transthyretin amyloidosis. Acoramidis is a small molecule stabilizer of transthyretin (TTR) for use in patients with TTR amyloidosis. Similar to the previously developed tafamidis, acoramidis is used to stabilize TTR in its tetrameric form, preventing the formation of amyloidogenic monomers and the progression of amyloidosis. Although they share a mechanism of action, acoramidis is more selective for TTR and is a more potent stabilizer when compared to tafamidis.
 
Acoramidis has been in development since at least 2013. It was approved by the FDA in November 2024 to reduce negative cardiovascular outcomes in patients with cardiomyopathy caused by TTR amyloidosis.